Cosmos Health Inc.

Analysis for Ticker: COSM

Cosmos Health Inc operates as a vertically integrated healthcare provider producing pharmaceuticals through Cana Laboratories SA and researching new drugs using an artificial intelligence platform called Cloudscreen. While it claims to be an innovative global entity, the math tells a story of a terminal hemorrhage where the company lost 19,1$ million in 2025 despite recording 65,2$ million in revenue. This is a disaster because the business burns more cash than it can ever hope to generate from selling vitamins and drugs, forcing it to survive by acting as a printing press for equity. To a child, it looks like a lemonade stand that costs 2$ to run for every 1$ it earns, so the owner keeps printing fake IOUs and giving them to his friends just to keep the lights on.